Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
CURRENT ASSETS:
Cash and cash equivalents	$ 121,461	$ 159,521
Marketable securities	192,663	184,420
Research and development tax credits receivable	1,659	1,280
Collaboration revenue receivable	3,996	1,525
Other receivables	1,358	1,518
Prepaid expenses	4,389	5,715
Total current assets	325,526	353,979
Property and equipment, net	5,396	4,228
Operating lease right-of-use assets	4,976	5,371
Other assets	408	497
TOTAL ASSETS	336,306	364,075
CURRENT LIABILITIES:
Accounts payable	3,620	461
Accrued expenses and other current liabilities	17,442	21,645
Operating lease liability, current portion	2,257	2,171
Deferred revenue, current portion	52,760	53,102
Income tax payable	4,856	1,240
Total current liabilities	80,935	78,619
Operating lease liability, net of current portion	2,780	3,257
Deferred revenue, net of current portion	1,347	2,682
TOTAL LIABILITIES	85,062	84,558
SHAREHOLDERS’ EQUITY
Preferred shares, no par value per share; unlimited shares authorized as of March 31, 2023 and December 31, 2022, respectively; 0 shares issued and outstanding as of March 31, 2022 and December 31, 2022, respectively	0	0
Common shares, no par value per share; unlimited shares authorized as of March 31, 2023 and December 31, 2022; 42,079,896 and 42,036,193 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively	482,677	482,032
Additional paid-in capital	43,056	37,226
Accumulated other comprehensive loss	(235)	(428)
Accumulated deficit	(274,254)	(239,313)
Total shareholders’ equity	251,244	279,517
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$ 336,306	$ 364,075